ECMM has launched the Candida IV study, involving over 100 sites worldwide

The European Confederation of Medical Mycology (ECMM) launched its fourth multicenter study, Candida IV, with Carelane's innovative technology significantly enhancing study operations. Carelane's platform facilitated the process by enabling site self-registration, real-time monitoring, and integrated capability assessments. Carelane’s collaborative protocol editing tools proved crucial in efficiently addressing these complex challenges, demonstrating our platform's pivotal role in advancing  research for AROs.